The 12th Brain Tumor Meeting will take place at the Max Delbrück Center in Berlin.

For 25 years, this meeting has brought together the international brain tumor community to discuss tumor biology, genetics, translational advances, and emerging therapeutic opportunities.

Why attend?

The meeting is designed to foster interdisciplinary exchange and catalyze new collaborations across basic, translational, and clinical research.

Who should attend?

Scientists, clinicians, neuro-oncologists and technical staff at all career stages are all welcome.

Abstracts for oral and poster presentations are welcome, and selected contributions will be recognized with presentation awards. As a new feature of this edition, early registrants may nominate speakers or suggest topics for the Scientific Committee to consider before finalizing the program.

Further information: